货号:GS40712
Teprotumumab is a fully human monoclonal antibody targeting insulin-like growth factor-1 receptor (IGF-1R). It blocks IGF-1R signaling, a pathway implicated in inflammation and tissue remodeling. It is approved for the treatment of Thyroid Eye Disease (TED), reducing proptosis (eye bulging), diplopia (double vision), and inflammation.
科技型中小企业
高新技术企业
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯